Bioprocessing symposium to showcase biopharma and purification innovation
29 January 2026 | By
The three-day MSS2026 event takes place in September in Slovenia, with online attendance options also available.
List view / Grid view
29 January 2026 | By
The three-day MSS2026 event takes place in September in Slovenia, with online attendance options also available.
Research findings support the design of robust microbial processes for pharmaceutical products.
The impurities research illustrates an approach that could offer a simpler and more flexible downstream purification process.
17 December 2025 | By Particle Measuring Systems
Join this webinar as we examine the main personnel-related factors that could lead to particle/microbial contamination risks of the product and outline practical measures that can mitigate these risks.
Investments in India, Korea and Singapore aim to reinforce its support for the region’s biopharma sector.
2 December 2025 | By Emerson
Is operational complexity limiting your performance? Discover how autonomous technologies are reducing risk and improving quality in pharma organisations.
Strengthens its downstream process offering with the addition of JSR’s Amsphere Protein A resin technology.
Bioprocess experts from Sartorius BIA Separations and BridgeBio Gene Therapy illustrate an approach with potential to expedite AAV upstream analytics and lower overall process development costs.
EPR Issue 3 includes articles on microbiology, downstream processing, manufacturing, drug formulation and more.
15 August 2025 | By Bruker Microbiology & Infection Diagnostics
This webinar explores the benefits of accelerated microbial identification using MALDI-TOF in pharmaceutical contamination control strategies.
11 August 2025 | By Entegris
This webinar explores the design and implementation of pre use post sterilisation integrity test assemblies (PUPSIT) in sterile filtration processes to ensure regulatory compliance while minimising operational risk.
2 July 2025 | By MasterControl
This webinar explores innovative, purpose-built AI solutions that elevate compliance and efficiency in quality and manufacturing operations.
Overcome matrix interferences in RNA–LNP endotoxin testing with LAL-based methods & recombinant factor C assays. Learn more in this whitepaper.
12 May 2025 | By Mettler Toledo
This virtual panel explores impurity control in pharmaceutical waters, the differences between microbial and organic contaminants, and best practices for measurement and treatment.
This article explores how artificial intelligence (AI) is forming an essential pillar of staying competitive in pharmaceutical manufacturing, with its adoption ensuring greater efficiency of medicine production in this fast-evolving sector.